natgillin/translations-raw huggingface dataset:
Steven-Johnson syndrome: if you experience painful red or purplish rash that spreads and blisters and/or other lesions begin to appear in the mucous membrane (e.g. mouth and lips), in particular if you had before light sensitivity, infections of the respiratory system (e.g. bronchitis) and/or fever.
Stevens-Johnsonov sindrom: če dobite boleč, rdeč ali škrlaten izpuščaj, ki se širi ali se začnejo pojavljati mehurji in/ali druge poškodbe na sluznici (npr. v ustih in na ustnicah), še posebno, če ste bili občutljivi na svetlobo ali imeli okužbe dihal (npr. bronhitis) in/ali zvišano telesno temperaturo.
Stevens - Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), including fatal cases, have been reported in patients who were receiving or had recently been treated with clofarabine.
Pri bolnikih, ki so prejemali ali so bili pred kratkim zdravljeni s klofarabinom, so poročali o Stevens- Johnsonovem sindromu (SJS) in toksični epidermalni nekrolizi (TEN) vključno s smrtnimi primeri.
Stevens Johnson syndrome, cold sweat
Stevens-Johnsonov sindrom, hladen znoj
Stevens Johnson syndrome, toxic epidermal necrolysis,
Stevens-Johnsonov sindrom, toksična epidermalna
Stevens Johnson syndrome, vesicular rash
Stevens-Johnsonov sindrom, vezikulozni izpuščaj
Stevens- Johnson syndrome†, erythema multiforme†, dermatitis bullous†
Stevens- Johnsonov sindrom†, multiformni eritem†, bulozni dermatitis
Stevens-Johnson
Johnsonov sindrom
Stevens-Johnson
Zelo redki
Stevens-Johnson syndrome
Stevens-Johnson sindrom
Stevens-Johnson syndrome (allergic reactions including serious skin rash, a high temperature and enlarged lymph nodes) (see section 2).
Stevens-Johnsonov sindrom (alergijska reakcija s hudim kožnim izpuščajem, zvišano telesno temperaturo in povečanjem bezgavk) (glejte poglavje 2)
Stevens-Johnson syndrome (serious illness with blistering of the skin, mouth, eyes and genitals), serious allergic reaction which causes swelling of the face or throat (angioedema)
Stevens-Johnsonov sindrom (resna bolezen z mehurji na koži, ustih, očeh in genitalijah), resne alergijske reakcije, ki povzročijo otekanje obraza ali grla (angioedem)
Stevens-Johnson syndrome (serious illness with blistering of the skin, mouth, eyes and genitals), serious allergic reaction which causes swelling of the face or throat (angioedema)
Stevens-Johnsonov sindrom (resna bolezen z mehurji na koži, ustih, očeh in genitalijah), resne alergične reakcije, ki povzročijo otekanje obraza ali grla (angioedem)
Stevens-Johnson syndrome (serious illness with blistering of the skin, mouth, eyes and genitals), serious allergic reaction which causes swelling of the face or throat (angioedema), sensitivity to sunlight
Stevens-Johnsonov sindrom (resna bolezen z mehurji na koži, ustih, očeh in genitalijah), resne alergične reakcije, ki povzročijo otekanje obraza ali grla (angioedem), občutljivost na sončno svetlobo
Stevens-Johnson syndrome (serious illness with blistering of the skin, mouth, eyes and genitals), serious allergic reaction which causes swelling of the face or throat (angioedema);
Stevens-Johnsonov sindrom (resna bolezen z mehurji na koži, ustih, očeh in genitalijah), resne alergične reakcije, ki povzročijo otekanje obraza ali grla (angioedem);
Stevens-Johnson Syndrome (SJS)*, Toxic Epidermal Necrolysis (TEN)*
Stevens-Johnsonov sindrom (SJS),* toksična epidermalna nekroliza (TEN)
Stevens-Johnson Syndrome (SJS),* Toxic Epidermal Necrolysis (TEN)*
Stevens-Johnsonov sindrom (SJS),* toksična epidermalna nekroliza (TEN)
Stevens-Johnson syndrome / toxic epidermal necrolysis*
Stevens-Johnsonov sindrom / toksična epidermalna nekroliza
Stevens-Johnson syndrome and toxic epidermal necrolysis (see section 4.4)
Stevens-Johnsonov sindrom in toksična epidermalna nekroliza (glejte poglavje 4.4)
Stevens-Johnson syndrome and toxic epidermal necrolysis: complicated, possibly life- threatening allergic reaction, severe inflammation of the outer and possibly inner skin, initially with fever, sore throat, and fatigue, skin rashes, leading to blisters, peeling, shedding of larger areas of skin, possible breathing difficulties and low blood pressure
Stevens-Johnson sindrom in toksična epidermalna nekroliza: zapletena, možno življenjsko ogrožajoča alergijska reakcija, hudo vnetje vrhnjice in možno tudi notranjih plasti kože, na začetku z zvišano telesno temperaturo, vnetim grlom in utrujenostjo, kožnimi izpuščaji, ki preidejo v mehurje, luščenjem večjih površin kože, možnimi težavami z dihanjem in nizkim krvnim tlakom;
Stevens-Johnson syndrome was approximately 0.1 %.
Pojavnost multiformnega eritema ali Stevens-Johnsonovega sindroma je bila približno 0,1 %.
Stevens-Johnson syndrome) or any of the other ingredients of this medicine (listed in section 6), or if you are allergic to teriflunomide (used to treat multiple sclerosis).
6) ali če ste alergični na teriflunomid (ki se uporablja za zdravljenje multiple skleroze).
Stevens-Johnson Syndrome), systemic lupus erythematosus or serious cardiac arrhythmias did not occur during the placebo-controlled studies of the epilepsy program with eslicarbazepine acetate.
Stevens-Johnsonov sindrom), sistemski erimatozni lupus ali hude srčne aritmije, se med študijami, nadzorovanimi s placebom programa zdravljenja epilepsije z eslikarbazepinacetatom, niso pojavile.
Stevens-Johnson syndrome* Pyoderma
luščenje kože kožne reakcijeu ekcem
Stevens-Johnson syndrome, erythema multiforme3, severe rash (< 1%)
Stevens-Johnsonov sindrom, multiformni eritem3, hud izpuščaj (<1 %)
Stevens-Johnson Syndrome, Exfoliative dermatitis
Stevens- Johnsonov sindrom, eksofoliativni dermatitis
Stevens-Johnson syndrome, phototoxicity, purpura, urticaria, dermatitis allergic, rash papular, rash macular, eczema
Stevens-Johnsonov sindrom, fototoksičnost, purpura, urtikarija, alergijski dermatitis, papulozni izpuščaj, makulozni izpuščaj, ekcem
Stevens-Johnson Syndrome, the treatment should be discontinued permanently.
Stevens-Johnsonov sindrom, je treba trajno ukiniti zdravljenje.
Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema mult iforme, Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]), see section 2.
Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, multiformni eritem, neželena reakcija z eozinofilijo in sistemskimi simptomi [sindrom DRESS]), glejte poglavje 2.
Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]), see section 2.
Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, multiformni eritem), neželena reakcija z eozinofilijo in sistemskimi simptomi [sindrom DRESS]), glejte poglavje 2.
Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, Drug Reaction with Eosinophilia and Systemic Symptoms [DRESS]), see section 2.
Stevens-Johnsonov sindrom, toksična epidermalna nekroliza, multiformni eritem, neželena reakcija z eozinofilijo in sistemskimi simptomi [sindrom DRESS]), glejte poglavje 2.
Stevens-Johnson syndrome/ toxic epidermal necrolysis
Stevens-Johnsonov sindrom/ toksična epidermalna nekroliza
Stevens-Johnson syndrome/toxic epidermal necrolysis (rare severe skin reaction).
Stevens-Johnsonov sindrom/toksična epidermalna nekroliza (redka huda kožna reakcija)
Stevens-Johnson syndrome1),
sindrom Stevens-Johnson,
Stevens-Johnson syndrome1, hypersensitivity vasculitis1, urticaria1, erythema multiforme1, alopecia1, toxic epidermal necrolysis (TEN)1
Stevens-Johnsonov sindrom1, preobčutljivostni vaskulitis1, urtikarija1, multiformni eritem1, alopecija1, toksična epidermalna nekroliza (TEN)1
Stevens-Johnson Syndrome6 Angio-neurotic oedema6
Stevens- Johnsonov sindrom6
Stevens-Johnson Syndrome6 Angio-neurotic oedema6
Stevens- Johnsonov sindrom6 angionevrotični edem6
Stevens-Johnson Syndrome6 Angio-neurotic oedema6
Stevens-Johnsonov sindrom6 angionevrotični edem6
Stevens-Johnson Syndrome6 Angio-neurotic oedema6
Stevens-Johnsonov sindrom6 angionevrotični edem6 fotosenzitivnostne reakcije
Stevens-Johnson Syndrome6 Angio-neurotic oedema6
Stevens-Johnsonov sindrom6, angionevrotični edem6
Stevens-Johnson syndrome7 Toxic epidermal necrolysis7
Stevens-Johnsonov sindrom7 toksična epidermalna nekroliza7
Stevens-Johnson syndrome: if you experience painful red or purplish rash that spreads and blisters and/or other lesions begin to appear in the mucous membrane (e.g. mouth and lips), in particular if you had before light sensitivity, infections of the respiratory system (e.g. bronchitis) and/or fever.
Stevens-Johnsonov sindrom: če dobite boleč, rdeč ali škrlaten izpuščaj, ki se širi ali se začnejo pojavljati mehurji in/ali druge poškodbe na sluznici (npr. v ustih in na ustnicah), še posebno, če ste bili občutljivi na svetlobo ali imeli okužbe dihal (npr. bronhitis) in/ali zvišano telesno temperaturo.
Stevens-Johnson syndrome; Lyell syndrome; Erythema multiforme; Photosensitivity
Stevens- Johnsonov sindrom, Lyellov sindrom, multiformni eritem, fotosenzitivnost
Stevens-Johnson Syndromef
Stevens-Johnsonov sindromf
Stevens-Johnson Syndrome†, Erythema Multiforme†, Dermatitis
Stevens- Johnsonov sindrom†, multiformni eritem†, bulozni dermatitis
Stevens-Johnson Syndrome†, Erythema Multiforme†, Dermatitis Bullous†
Johnsonov sindrom†, multiformni eritem†, bulozni dermatitis
Stevens-Johnson syndrome†, Erythema multiforme†, Dermatitis bullous†
Stevens- Johnsonov sindrom†, multiformni eritem†, bulozni dermatitis
Stick it on the blister, just above the row of white active tablets where it reads ‘Place day label here’.
Prilepite jo na pretisni omot, tik nad vrsto belih aktivnih tablet, kjer piše "sem prilepite nalepko z dnevnimi oznakami".
Stick the patch onto a different area of skin each day, for example on the right side of your body one day, then on the left side the next day; on your upper body one day, then on your lower body.
Obliž zdravila Leganto vsak dan nalepite na drugo mesto na koži (na primer na desno stran telesa en dan, nato na levo stran naslednji dan ter na zgornji del telesa en dan, nato na spodnji del telesa).
Stick the patch onto a different area of skin each day, for example on the right side of your body one day, then on the left side the next day; on your upper body one day, then on your lower body.
Obliž zdravila Neupro vsak dan nalepite na drugo mesto na koži (na primer na desno stran telesa en dan, nato na levo stran naslednji dan ter na zgornji del telesa en dan, nato na spodnji del telesa).
Stick the patch onto your lower abdomen, below your waist.
Obliž nalepite na spodnji del trebuha, pod pas.
Stick to realistic calorie and fat targets as this is a good way of maintaining your weight loss achievements in the long-term.
Določite si realne ciljne vrednosti kalorij in maščob saj je to dobra pot izgube telesne mase in njenega vzdrževanja skozi daljše obdobje
Sticky eyes
lepljive oči,
Stiff joints, rib pain
togi sklepi, bolečina v rebrih
Still higher doses (725 mg/kg) produced, in addition, convulsions and death.
Še večji odmerek (725 mg/kg) pa povzroči krče in pogin.
Still’s Disease
Stillova bolezen
Still’s Disease (AOSD and SJIA)
Stillova bolezen (AOSD in SJIA)
Still’s disease including AOSD and SJIA is an inflammatory disease that can cause pain, swelling and inflammation of one or more joints, as well as rash and fever.
Stillova bolezen, ki vključuje Stillovo bolezen z začetkom v odrasli dobi (AOSD) in sistemski juvenilni idiopatski artritis (SJIA) je vnetna bolezen, ki lahko povzroča bolečine, otekanje in vnetje v enem ali več sklepih, lahko povzroča tudi izpuščaj in zvišano telesno temperaturo.
Still’s disease including AOSD and SJIA is an inflammatory disease that can cause pain, swelling and inflammation of one or more joints, as well as rash and fever.
Stillova bolezen, ki vključuje Stillovo bolezen z začetkom v odrasli dobi (AOSD) in sistemski juvenilni idiopatski artritis (SJIA), je vnetna bolezen, ki lahko povzroča bolečine, otekanje in vnetje v enem ali več sklepih, lahko povzroča tudi izpuščaj in zvišano telesno temperaturo.
Still’s Disease SJIA
Stillova bolezen
Still’s disease, including adult-onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (SJIA), rare diseases causing inflammation of joints as well as rash and fever.
Stillove bolezni, tudi Stillove bolezni, ki se začne v odrasli dobi (AOSD), in sistemskega juvenilnega idiopatskega artritisa (SJIA), redke otroške bolezni, ki povzroča vnetje sklepov, izpuščaje in povišano telesno temperaturo.
STIMULANTS
PSIHOSTIMULANSI
Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT).
Spodbujanje razvoja več foliklov pri bolnicah, pri katerih je treba izzvati superovulacijo v postopkih asistirane reprodukcije (ART), kot so oploditev in vitro (IVF), prenos gamete v jajcevod (GIFT) in prenos zigote v jajcevod (ZIFT).
Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.
Spodbujanje razvoja več foliklov pri ženskah, pri katerih je potrebno izzvati superovulacijo v postopkih asistirane reprodukcije (ART), kot so in vitro oploditev (IVF), prenos gamete v jajcevod in prenos zigote v jajcevod.
Stimulation of multifollicular development in women undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer and zygote intra-fallopian transfer.
Spodbujanje razvoja več foliklov pri ženskah, pri katerih je potrebno izzvati superovulacijo v postopkih asistirane reprodukcije (ART, assisted reproductive technology), kot so in vitro oploditev (IVF), prenos gamete v jajcevod in prenos zigote v jajcevod.
Stimulation of the AT1 receptor is responsible for pathologic effects of angiotensin II in the kidney and other organs associated with angiotensin II such as vasoconstriction, retention of sodium and water, increased aldosterone synthesis and organ remodeling.
Stimulacija receptorja AT1 je odgovorna za patološke učinke angiotenzina II v ledvicah in drugih organih, povezanih z angiotenzinom II, kot so vazokonstrikcija, zadrževanje natrija in vode, povečana sinteza aldosterona in preoblikovanje organa.
Stir and drink immediately
Zmešajte in takoj popijte.
Stir and drink immediately.
Zmešajte in takoj popijte.
Stir the tablet until it has dispersed into the water.
Tableto mešajte, dokler se ne raztopi v vodi.
Stir the water until the tablet breaks up into very small pieces - the tablet will not completely dissolve.
Vodo mešajte, dokler se tableta ne razpusti v zelo majhne delce – tableta se ne bo popolnoma raztopila.
Stir to make sure there is no drug residue remaining in the container (illustration e).
Premešajte in se prepričajte, da v posodi ni ostankov zdravila (slika e).
Stir until the tablet breaks up (the mixture will not be clear) then drink the mixture straight away or within 30 minutes.
Mešajte, dokler se tableta ne razpusti (mešanica ne bo bistra), nato mešanico popijte takoj ali v 30 minutah.
Stir until the tablet(s) dissolve completely.
Mešajte, dokler se tableta/tablete popolnoma ne raztopi(jo).
Stir with a spoon until the tablets have completely dissolved.
Mešajte z žlico, dokler se tablete popolnoma ne raztopijo.
Stir with the small spoon or clean utensil until the tablets dissolve.
Z žličko ali čistim pripomočkom mešajte, dokler se tablete ne raztopijo.
Stiripentol enhances the central depressant effect of chlorpromazine.
Stiripentol poveča učinek klorpromazina na osrednje živčevje.
Stiripentol may cause dizziness and ataxia that may affect ability to drive and use machines and patients should not drive or use machinery whilst on stiripentol therapy.
Stiripentol lahko povzroči omotico in ataksijo, ki lahko vplivata na sposobnost vožnje in upravljanja s stroji, zato bolniki, ki se zdravijo s stiripentolom, ne smejo voziti ali upravljati s stroji.
Stiripentol powder for oral suspension in sachet contains aspartame, a source of phenylalanine.
Stiripentol v obliki praška za peroralno suspenzijo v vrečkah vsebuje aspartam, ki je vir fenilalanina.
Stiripentol should not be taken with milk or dairy products (yoghurt, soft cream cheese, etc.), carbonated drinks, fruit juice or food and drinks that contain caffeine or theophylline.
Stiripentol se ne sme jemati z mlekom ali mlečnimi izdelki (jogurt, sir za mazanje, itn.), gaziranimi pijačami, sadnim sokom ali živili in pijačami, ki vsebujejo kofein ali teofilin.
Stiripentol, the active ingredient of Diacomit, belongs to a group of medicines called antiepileptics.
Zdravilo Diacomit, ki vsebuje zdravilno učinkovino stiripentol, spada v skupino antiepileptikov.
Stiripentol, the active ingredient of Diacomit, belongs to a group of medicines called antiepileptics.
Zdravilo Diacomit, ki vsebuje zdravilno učinkovino stiripentol, spada v skupino antiepileptikov..
Stivarga 40 mg film-coated tablets.
Stivarga 40 mg filmsko obložene tablete
Stivarga 40 mg tablets are available in packs containing one bottle of 28 tablets and in a pack comprising 3 bottles, each containing 28 tablets.
Zdravilo Stivarga 40 mg je na voljo v pakiranju, ki vsebuje 1 plastenko z 28 tabletami in pakiranju s 3 plastenkami; ena plastenka vsebuje 28 tablet.
Stivarga can cause severe bleeding in the digestive system such as stomach, throat, rectum or intestine, or in the lungs, kidneys, mouth, vagina and/or brain.
Zdravilo Stivarga lahko povzroči hude krvavitve v prebavilih, npr. v želodcu, požiralniku, danki ali črevesju, ali v pljučih, ledvicah, ustih, nožnici in/ali možganih.
Stivarga had been shown to delay the worsening of the disease in these patients and its side effects are manageable.
Za zdravilo Stivarga je bilo dokazano, da odloži poslabšanje bolezni pri teh bolnikih, njegovi neželeni učinki pa so obvladljivi.
Stivarga has been associated with an increased incidence of electrolyte abnormalities (including hypophosphatemia, hypocalcaemia, hyponatraemia and hypokalaemia) and metabolic abnormalities (including increases in thyroid stimulating hormone, lipase and amylase).
Zdravilo Stivarga povezujejo z večjo incidenco nenormalnih vrednosti elektrolitov (vključno s hipofosfatemijo, hipokalciemijo, hiponatriemijo in hipokaliemijo) in presnovnimi motnjami (vključno s povečanjem vrednosti tiroideo stimulirajočega hormona, lipaze in amilaze).
Stivarga is an anticancer medicine that contains the active substance regorafenib.
Stivarga je zdravilo proti raku, ki vsebuje zdravilno učinkovino regorafenib.
Stivarga is indicated for the treatment of adult patients with
Zdravilo Stivarga je indicirano za zdravljenje odraslih bolnikov z:
Stivarga is not recommended for use in patients with severe hepatic impairment (Child-Pugh C) as Stivarga has not been studied in this population and exposure might be increased in these patients.
Zdravila Stivarga se ne priporoča za uporabo pri bolnikih s hudo okvaro jeter (Child-Pugh C), ker zdravila Stivarga niso preučevali pri tej populaciji in je lahko izpostavljenost pri teh bolnikih povečana.
Stivarga is used to treat: colon or rectal cancer that has spread to other parts of the body in adult patients who have received other treatments or cannot be treated with other medicines (fluoropyrimidine-based chemotherapy, an anti-VEGF therapy and an anti-EGFR therapy). gastrointestinal stromal tumors (GIST), a type of cancer of the stomach and bowel, that has spread to other parts of the body or is not amenable to surgery, in adult patients who have been previously treated with other anticancer medicines (imatinib and sunitinib).
Zdravilo Stivarga se uporablja za zdravljenje: raka debelega črevesa ali danke, ki se je razširil na druge dele telesa, pri odraslih bolnikih, ki so že prejeli druge oblike zdravljenja, ali jih ni mogoče zdraviti z drugimi zdravili (kemoterapija na osnovi fluoropirimidina, zaviralci VEGF in zaviralci EGFR). gastrointestinalnih stromalnih tumorjev (GIST), vrsto raka želodca in črevesja, ki se je razširil na druge dele telesa ali ga ni mogoče operirati, pri odraslih bolnikih, ki so se pred tem zdravili z drugimi zdravili proti raku (imatinib in sunitinib).
Stivarga plus BSC§ (N=132)
Zdravilo Stivarga in najboljša podporna oskrba§ (N = 132)
Stivarga plus BSC§ (N=133)
Zdravilo Stivarga in najboljša podporna oskrba§ (N = 133)
Stivarga plus BSC§ (N=136)
Zdravilo Stivarga in najboljša podporna oskrba§ (N = 136)
Stivarga plus BSC§ (N=500)
Zdravilo Stivarga in najboljša podporna oskrba § (N = 500)
Stivarga plus BSC§ (N=505)
zdravilo Stivarga in najboljša podporna oskrba§ (N = 505)
STOCRIN 100 mg hard capsules
STOCRIN 100 mg trde kapsule
Stocrin 100 mg hard capsules are supplied in bottles of 30 capsules.
Stocrin 100 mg trde kapsule so na voljo v plastenkah s 30 kapsulami.
Stocrin 100 mg hard capsules efavirenz
Stocrin 100 mg trde kapsule efavirenz
STOCRIN 100 mg hard capsules White, printed with “3807”.
STOCRIN 100 mg trde kapsule Bele barve, z napisom "3807".
Stocrin 200 mg capsules are supplied in bottles of 90 capsules and in packs containing 42 x 1 capsules in aluminium perforated unit dose blisters.
Stocrin 200 mg trde kapsule so na voljo v plastenkah z 90 kapsulami ter v škatlah z 42 x 1 kapsulo v perforiranih aluminijastih pretisnih omotih za enkratni odmerek.
Stocrin 200 mg film-coated tablets efavirenz
Stocrin 200 mg filmsko obložene tablete efavirenz
STOCRIN 200 mg hard capsules
STOCRIN 200 mg trde kapsule
STOCRIN 200 mg hard capsules efavirenz
STOCRIN 200 mg trde kapsule efavirenz
STOCRIN 200 mg hard capsules For bottles: 3 years.
STOCRIN 200 mg trde kapsule Za plastenke: 3 leta
STOCRIN 30 mg/ml oral solution efavirenz
STOCRIN 30 mg/ml peroralna raztopina efavirenz
STOCRIN 50 mg film-coated tablets efavirenz
STOCRIN 50 mg filmsko obložene tablete efavirenz
STOCRIN 50 mg hard capsules
STOCRIN 50 mg trde kapsule
Stocrin 50 mg hard capsules are supplied in bottles of 30 capsules.
Stocrin 50 mg trde kapsule so na voljo v plastenkah s 30 kapsulami.
Stocrin 50 mg hard capsules efavirenz
Stocrin 50 mg trde kapsule efavirenz
STOCRIN 50 mg hard capsules STOCRIN 100 mg hard capsules STOCRIN 200 mg hard capsules
STOCRIN 50 mg trde kapsule STOCRIN 100 mg trde kapsule STOCRIN 200 mg trde kapsule
Stocrin 50 mg, 200 mg and 600 mg film-coated tablets are available.
Na voljo so Stocrin 50 mg, 200 mg in 600 mg filmsko obložene tablete.
Stocrin 600 mg film-coated tablets efavirenz
Stocrin 600 mg filmsko obložene tablete efavirenz
Stocrin can reduce the amount of statins in your blood.
Zdravilo Stocrin lahko zmanjša količino statinov v krvi.
Stocrin does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Zdravilo Stocrin ne ozdravi okužbe z virusom HIV ali aidsa, vendar pa lahko upočasni slabšanje imunskega sistema in razvoj okužb in bolezni, povezanih z aidsom.
Stocrin Dose (mg)
Stocrin odmerek (mg)
Stocrin Dose (mg)*
Stocrin odmerek (mg)
Stocrin has also been studied in 57 children aged between three and 16 years, in combination with nelfinavir and other antiviral medicines.
Zdravilo Stocrin so proučevali tudi pri 57 otrocih, starih med tri in 16 let, v kombinaciji z nelfinavirom in drugimi protivirusnimi zdravili.
STOCRIN has not been adequately studied in patients with advanced HIV disease, namely in patients with CD4 counts < 50 cells/mm3, or after failure of protease inhibitor (PI) containing regimens.
Uporabe zdravila STOCRIN še niso dovolj preučili pri bolnikih z napredovano boleznijo HIV, to je pri bolnikih z vrednostjo CD4 < 50 celic/mm3, ali po neuspelem zdravljenju z režimom, ki je vključeval zaviralce proteaze (ZP).
Stocrin is a medicine that contains the active substance efavirenz.
Zdravilo Stocrin je zdravilo, ki vsebuje zdravilno učinkovino efavirenz.